BIO-RAD LABORATORIES, INC. executive Courtney C. Enloe exercised Options covering 1,453 shares at $0 per share between Sep. 5 and Sep. 6, 2026. Investors can also see resulting holdings of 1,652 shares, 2,876 derivative securities after an award, and 1,536 derivative securities after the exercises.
Key Highlights
- Courtney C. Enloe received 2,876 derivative securities on Sep. 4, 2026.
- The reported forfeiture transactions carried a price of $386.11 per share.
- The Sep. 4 award represented about 100.0% of Enloe’s resulting derivative securities holding.
BIO-RAD LABORATORIES, INC. (NYSE: BIO) executive Courtney C. Enloe exercised options covering 1,453 shares at $0 per share between Sep. 5 and Sep. 6, 2026. Enloe’s reported derivative securities holding after those exercises was 1,536.
Award and Forfeiture Transactions
Enloe received 2,876 derivative securities on Sep. 4, with the resulting derivative securities holding also reported at 2,876. That award represented about 100.0% of the resulting derivative securities position. The transactions were recorded across the Sep. 5 and Sep. 6 period.
Transaction Codes Separate Holding Types
The A code identifies the Sep. 4 award or grant of derivative securities. The reported holdings following the transactions were 1,652 shares and 1,536 derivative securities. The award transaction separately resulted in 2,876 derivative securities.
FAQs
Q: What did Bio-Rad executive Courtney Enloe receive?
A: Courtney C. Enloe received 2,876 derivative securities on Sep. 4, 2026. The award represented about 100.0% of the resulting derivative securities holding.
Q: How did the Bio-Rad insider transactions affect reported holdings?
A: Enloe’s reported holding was 1,652 shares after the forfeiture transactions and 1,536 derivative securities after the option exercises. The exercises were priced at $0 per share.
Q: What does BIO option code M mean?
A: The M transaction code identifies an option exercise. Enloe’s M-coded transactions covered 1,453 shares at $0 per share between Sep. 5 and Sep. 6, 2026.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.